Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: A pilot study-Reference-Cited by-同舟云学术

Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: A pilot study

Published:2001-04 Issue:4 Volume:16 Page:406-415
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Ikeda Kenji,Saitoh Satoshi,Kobayashi Masahiro,Suzuki Yoshiyuki,Suzuki Fumitaka,Tsubota Akihito,Arase Yasuji,Murashima Naoya,Chayama Kazuaki,Kumada Hiromitsu

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1746.2001.02450.x/fullpdf

Reference37 articles.

1. PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS

2. PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA

3. Hepatitis C–associated hepatocellular carcinoma

4. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment;Cancer Medicine;2019-02-21

2. Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis;BMC Gastroenterology;2017-04-04

3. Oncogenic Viruses and Hepatocellular Carcinoma;Clinics in Liver Disease;2015-05

4. Risk factors for liver-related mortality in chronic hepatitis C patients: A deceased case-living control study;World Journal of Gastroenterology;2014

5. 2. Current Therapy for Chronic Hepatitis C;Nihon Naika Gakkai Zasshi;2014